Hemorrhoids |
|
|
Clinical Trial: Trial to Evaluate Effect of Lactulose on Hard Stools in Patients with Hemorrhoids or Anal Fissures
This study is currently recruiting patients.
Verified by Solvay Pharmaceuticals September 2005
|
Purpose
| Condition | Intervention | Phase |
|---|---|---|
| hemorrhoids; anal fissures | Drug: Lactulose | Phase IV |
MedlinePlus consumer health information
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title: An Open, Randomized, Parallel Group, Single Center Study to Investigate the Effect of Lactulose Versus Plantago Ovata on the Quality of Life of Patients with Hard Stools and Hemorrhoids or Anal Fissure.
Eligibility
Inclusion Criteria:
Patients suffering from symptomatic hemorrhoids, or symptomatic anal fissure.
Exclusion Criteria:
Patients suffering from malignant tumor in the intestine or the anal-rectal region, irritable colon, intestine inflammatory disease.
Location and Contact Information
Spain
Site 1, Valencia, Spain; Terminated
Site 2, Barcelona, Spain; Recruiting
Site 3, Sant Cugat del Vallès (Barcelona), Spain; Recruiting
Site 4, Sabadell, Barcelona, Spain; Recruiting
Site 5, Huesca, Spain; Recruiting
Site 6, Granada, Spain; Terminated
Site 7, Oviedo, Spain; Recruiting
Site 8, Santiago de Compostela, Spain; Recruiting
Global Clinical Director Solvay, Study Director, Solvay Pharmaceuticals
More Information
Last Updated: September 11, 2005
Record first received: September 9, 2005
ClinicalTrials.gov Identifier: NCT00160290
Health Authority: Spain: Spanish Agency of Medicines
ClinicalTrials.gov processed this record on 2005-09-13

Not Signed In -

